PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 131 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $55,000 | -49.1% | 14,421 | -44.2% | 0.01% | -42.1% |
| Q4 2018 | $108,000 | -25.0% | 25,867 | +55.9% | 0.02% | -51.3% |
| Q4 2016 | $144,000 | +17.1% | 16,596 | -41.5% | 0.04% | +18.2% |
| Q1 2016 | $123,000 | -10.9% | 28,359 | +53.3% | 0.03% | -31.2% |
| Q2 2015 | $138,000 | – | 18,500 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVERENCE CAPITAL MANAGEMENT INC | 28,980 | $123,000 | 0.01% |
| Daiwa Securities Group Inc. | 533 | $2,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 138,663 | $52,000 | 0.00% |